NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1194130054
Verify on CMS → Ghulam Rehman Mohy-Ud-Din
Hematology & Oncology Physician in Salt Lake City, Utah.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
501
Medicare Part D claims · 52 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.1/100
▲ 9 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Ghulam Rehman Mohy-Ud-Din reported a CMS MIPS final score of 92.1/100 - above the 83.1 national average - and filed 501 Medicare Part D claims in 2023.
- 92.1/100
- MIPS score · +9 vs avg
- 501
- Part D claims, 2023
- 77%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ghulam Rehman Mohy-Ud-Din's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
92 Top 32% higher than 68% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ghulam Rehman Mohy-Ud-Din sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ghulam Rehman Mohy-Ud-Din writes more Part D claims than 37% of them and scores higher on MIPS quality than 66% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Ghulam Rehman Mohy-Ud-Din. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Ghulam Rehman Mohy-Ud-Din practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ghulam Rehman Mohy-Ud-Din?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
501 41% vs specialty avg
MIPS final score
92.1/100 9 pts vs avg
Specialty distribution in Utah
How Hematology & Oncology Physician compares to other specialties among Utah providers
Medicare quality performance, MIPS
Ghulam Rehman Mohy-Ud-Din's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 92.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 92.1/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ghulam Rehman Mohy-Ud-Din appears in the CMS NPPES registry as a Hematology & Oncology Physician provider at 1950 CIRCLE OF HOPE DR, Salt Lake City, UT, 84112, with a listed phone of (801) 587-7000. NPI 1194130054 was issued on 06/30/2014.
Medicare Part D records for calendar year 2023 show 501 prescription claims written by this provider, covering 52 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 23% brand-name and 77% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.1/100 for the 2023 performance year (Quality 85.6), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1194130054 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Gender | Male |
| NPI Issued | 06/30/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
92.0664
Final Score
Avg: 83.1
85.5753
Quality
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Ghulam Rehman Mohy-Ud-Din bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University OF Utah Adult Services
Salt Lake City, UT
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Ghulam Rehman Mohy-Ud-Din - brand share 23.0%
Hematology & Oncology Physician average
23% brand-name claims vs 77% generic, on 501 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
501
Total Claims
$1.3M
Total Drug Cost
52
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 718
- Total Day Supply
- 19,876
- Brand vs Generic
- 23% brand / 77% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $54K
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 2.93
- Gender Split
- 52% female / 48% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ghulam Rehman Mohy-Ud-Din prescribes most
Top Medicare Part D drugs by claim count, 2023
- Acyclovir
Acyclovir
115 claims
- Revlimid
Revlimid
61 claims
- Dexamethasone
Dexamethasone
53 claims
- Omeprazole
Omeprazole
46 claims
- Eliquis 25
Eliquis
25 claims
- Ondansetron Hcl 25
Ondansetron Hcl
25 claims
- Xarelto 12
Xarelto
12 claims
- Gabapentin 11
Gabapentin
11 claims
| Drug | Claims |
|---|---|
| Acyclovir | 115 |
| Revlimid Lenalidomide | 61 |
| Dexamethasone | 53 |
| Omeprazole | 46 |
| Eliquis Apixaban | 25 |
| Ondansetron Hcl | 25 |
| Xarelto Rivaroxaban | 12 |
| Gabapentin | 11 |
| Prochlorperazine Maleate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Ghulam Rehman Mohy-Ud-Din fits within the Hematology & Oncology Physician landscape nationally.
11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Ghulam Rehman Mohy-Ud-Din's 501 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Utah
Other clinicians with the same primary specialty enrolled in Utah, drawn from the same CMS NPPES roster as Mohy-Ud-Din.
Dr. Candice Baldeo
MD
Salt Lake City, UT
Dr. Anna Beck
MD
Salt Lake City, UT
Dr. Ali Ben-Jacob
MD
Logan, UT
Dr. Wendy Breyer
MD
Murray, UT
Dr. Scott Browning
MD
Salt Lake City, UT
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Utah medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Utah
Frequently Asked Questions
What is Ghulam Rehman Mohy-Ud-Din's specialty? ▼
Ghulam Rehman Mohy-Ud-Din specializes in Hematology & Oncology Physician and practices in Salt Lake City, Utah.
How much does Ghulam Rehman Mohy-Ud-Din prescribe under Medicare Part D? ▼
In 2023, Ghulam Rehman Mohy-Ud-Din wrote 501 Medicare Part D claims totaling $1.3M in drug costs for 52 beneficiaries.
What is Ghulam Rehman Mohy-Ud-Din's Medicare quality score? ▼
Ghulam Rehman Mohy-Ud-Din has a CMS MIPS Final Score of 92.1/100 (Quality: 85.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ghulam Rehman Mohy-Ud-Din located? ▼
Ghulam Rehman Mohy-Ud-Din is located at 1950 CIRCLE OF HOPE DR, Salt Lake City, UT, 84112. Phone: (801) 587-7000.
What is Ghulam Rehman Mohy-Ud-Din's NPI number? ▼
Ghulam Rehman Mohy-Ud-Din's National Provider Identifier (NPI) is 1194130054, issued on 06/30/2014.
Does Ghulam Rehman Mohy-Ud-Din prescribe more brand-name or generic drugs? ▼
Ghulam Rehman Mohy-Ud-Din's prescribing is 23% brand-name and 77% generic drugs by claim count, with $1.2M in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Ghulam Rehman Mohy-Ud-Din prescribe most often? ▼
Based on 2023 Medicare Part D data, Ghulam Rehman Mohy-Ud-Din's most frequently prescribed drugs include Acyclovir, Revlimid, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ghulam Rehman Mohy-Ud-Din accept Medicare? ▼
Ghulam Rehman Mohy-Ud-Din appears in CMS Medicare data with 501 Part D claims and 52 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ghulam Rehman Mohy-Ud-Din's credentials? ▼
Ghulam Rehman Mohy-Ud-Din's NPI is 1194130054. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.